Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial

Anne-Lise Poirier, Fabrice Kwiatkowski, Jean-Marie Commer, Bénédicte D'Aillières, Virginie Berger, Mariette Mercier, Franck Bonnetain, Anne-Lise Poirier, Fabrice Kwiatkowski, Jean-Marie Commer, Bénédicte D'Aillières, Virginie Berger, Mariette Mercier, Franck Bonnetain

Abstract

Background: The end of life for cancer patients is the ultimate stage of the disease, and care in this setting is important as it can improve the wellbeing not only of patients, but also the patients' family and close friends. As it is a matter of profoundly personal concerns, patients' perception of this phase of the disease is difficult to assess and has thus been insufficiently studied. Nonetheless, caregivers are required to provide specific care to help patients and to treat them in order to improve their wellbeing during this period.While tools to assess health-related quality of life (QoL) in cancer patients at the end of life exist in English, to our knowledge, no validated tools are available in French.

Methods/design: This randomized multicenter cohort study will be carried out to cross-culturally adapt and validate a French version of the English QUAL-E and the Missoula Vitas Quality Of Life Index (MVQOLI) questionnaires for advanced cancer patients in a palliative setting. A randomized clinical trial component in addition to a cohort study is implemented in order to test psychometric hypotheses: order effect and improvement of sensibility to change.The validation procedure will ensure that the psychometric properties are maintained.The main criterion to assess the reliability of the questionnaires will be reproducibility (test-retest method) using intraclass correlation coefficients. It will be necessary to include 372 patients. The sensitivity to change, discriminant capability as well as convergent validity will be also investigated.

Discussion: If the cross-cultural validation of the MVQOLI and QUAL-E questionnaires for advanced cancer patients in a palliative setting have satisfactory psychometric properties, it will allow us to assess the specific dimensions of QoL at the end of life.

Trial registration: Current Controlled Trials NCT01545921.

References

    1. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. J Am Med Assoc. 2008;300:1665–1673. doi: 10.1001/jama.300.14.1665.
    1. Patrick LD, Curtis JR, Engelberg RA, Nielsen E, McCown E. Measuring and improving the quality of dying and death. Ann Intern Med. 2003;139:410–415.
    1. Lamont EB. A demographic and prognostic approach to defining the end of life. J Palliat Med. 2005;8(Suppl 1):S12–S21.
    1. Emery MP, Perrier LL, Acquadro C. Patient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questions. Health Qual Life Outcomes. 2005;3:12. doi: 10.1186/1477-7525-3-12.
    1. Kirkova J, Davis MP, Walsh D, Tiernan E, O'Leary N, LeGrand SB, Lagman RL, Russell KM. Cancer symptom assessment instruments: a systematic review. J Clin Oncol. 2006;24:1459–1473. doi: 10.1200/JCO.2005.02.8332.
    1. Jordhoy MS, Ringdal GI, Helbostad JL. Oldervoll Jon Håvard L, Kaasa S: Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care. Palliat Med. 2007;21:673–682. doi: 10.1177/0269216307083386.
    1. Beitz J, Gnecco C, Justice R. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective. J Natl Cancer Inst Monogr. 1996. pp. 7–9.
    1. Bonnetain F. Health related quality of life and endpoints in oncology. Cancer Radiother. 2010;14:515–518. doi: 10.1016/j.canrad.2010.06.001.
    1. Huskisson EC. Measurement of pain. Lancet. 1974;2:1127–1131.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Santana MJ, Au HJ, Dharma-Wardene M, Hewitt JD, Dupere D, Hanson J, Ghosh S, Feeny D. Health-related quality of life measures in routine clinical care: can FACT-fatigue help to assess the management of fatigue in cancer patients? Int J Technol Assess Health Care. 2009;25:90–96. doi: 10.1017/S0266462309090126.
    1. Aspinal F, Hughes R, Dunckley M, Addington-Hall J. What is important to measure in the last months and weeks of life? A modified nominal group study. Int J Nurs Stud. 2006;43:393–403. doi: 10.1016/j.ijnurstu.2005.06.005.
    1. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. J Am Med Assoc. 2000;284:2476–2482. doi: 10.1001/jama.284.19.2476.
    1. Byock I, Merriman M. Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index. J Palliat Med. 1998;12:231–244. doi: 10.1191/026921698670234618.
    1. Teno JM, Byock I, Field MJ. Research agenda for developing measures to examine quality of care and quality of life of patients diagnosed with life-limiting illness. J Pain Symptom Manage. 1999;17:2.
    1. Stewart AL, Teno J, Patrick DL, Lynn J. The concept of quality of life of dying persons in the context of health care. J Pain Symptom Manage. 1999;17:2.
    1. Zhang B, Wright AA, Huskamp HA, Nilsson ME, Maciejewski ML, Earle CC, Block SD, Maciejewski PK, Prigerson HG. Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med. 2009;169:480–488. doi: 10.1001/archinternmed.2008.587.
    1. Steinhauser KE, Bosworth HB, Clipp EC, McNeilly M, Christakis NA, Parker J, Tulsky JA. Initial assessment of a new instrument to measure quality of life at the end of life. J Palliat Med. 2002;5:6.
    1. Melzack R. The McGill pain questionnaire: from description to measurement. Anesthesiology. 2005;103:199–202. doi: 10.1097/00000542-200507000-00028.
    1. Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Oeirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R. Development and initial validation of an expanded and revised version of the short-form McGill pain questionnaire (Sf-MPQ-2) Pain. 2009;144:35–42. doi: 10.1016/j.pain.2009.02.007.
    1. Higginson IJ, McCarthy M. Validity of the support team assessment schedule: do staff's ratings reflect those made by patients or their families? Palliat Med. 1993;7:219–228. doi: 10.1177/026921639300700309.
    1. Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, De Graeff A, Hammerlid E, Kaasa S, Sprangers MAG. JB Bjorner for the EORTC Quality of Life Group: The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2006;42:55–64. doi: 10.1016/j.ejca.2005.06.022.
    1. Osoba D, Rodriguez G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality of life scores. J Clin Oncol. 1998;16:139–144.
    1. Fayers PM, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual. 3. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
    1. Steinhauser KE, Bosworth HB, Clipp EC, McNeilly M, Christakis NA, Parker J, Tulsky JA. Measuring quality of life at the end of life: validation of the QUAL-E. Palliat Support Care. 2004;2:3–14.
    1. Schwartz CE, Merriman MP, Reed G, Byock I. Evaluation of the Missoula-VITAS quality of life index - revised: research tool or clinical tool? J Palliat Med. 2005;8:121–135. doi: 10.1089/jpm.2005.8.121.
    1. Streiner DL, Norman GR. Health Measurement Scales. A practical guide to their development and use. Oxford: Oxford University Press; 1989.
    1. Bernhard J, Cella DF, Coates AS, Fallowfield L, Ganz PA, Moinpour CM, Osaba D, Simes J, Hürny C. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med. 1998;17:517–532. doi: 10.1002/(SICI)1097-0258(19980315/15)17:5/7<517::AID-SIM799>;2-S.
    1. Addington-Hall J, Kalra L. Measuring quality of life. Who should measure quality of life? BMJ. 2001;322:1417–1420. doi: 10.1136/bmj.322.7299.1417.
    1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–415. doi: 10.1016/0197-2456(89)90005-6.
    1. Swaine-Verdier A, Doward LC, Hagell P, Thorsen H, McKenna S. Adapting Quality of Life Instruments. Value in Health. 2004;7(Suppl 1):S27–S30.
    1. Reneman MF, Dijkstra A, Geertzen JH, Dijkstra PU. Psychometric properties of chronic pain acceptance questionnaires: a systemic review. Eur J Pain. 2010;14:457–565. doi: 10.1016/j.ejpain.2009.08.003.
    1. Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fossa SD, Kaasa S. Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity. Int J Radiat Oncol Biol Phys. 2010;77:793–804. doi: 10.1016/j.ijrobp.2009.05.057.
    1. Ornetti P, Parratte S, Gossec L, Tavernier C, Argenson JN, Roos EM, Guillemin F, Maillefert JF. Cross-cultural adaptation and validation of the French version of the Knee injury and Osteoarthritis Outcome Score (KOOS) in knee osteoarthritis patients. Osteoarthr Cartil. 2008;16(4):423–428. doi: 10.1016/j.joca.2007.08.007. Epub 2077 Oct 1.
    1. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32:307–317. doi: 10.2307/2987937.
    1. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310.
    1. Rubin DB. Inference and missing data. Biometrika. 1976;63:581–592. doi: 10.1093/biomet/63.3.581.
    1. Diggle P, Kenward MG. Informative drop-out in longitudinal data analysis. Applied Statistics. 1994;43:49–93. doi: 10.2307/2986113.
    1. Cnaan A, Laird NM, Slasor P. Tutorial in biostatistics. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16:2349–2380. doi: 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>;2-E.
    1. Dabakuyo TS, Fraisse J, Causeret S, Gouy S, Padeano MM, Loustalot C, Cuisenier J, Sauzedde JM, Smail M, Combier JP, Chevillote P, Rosburger C, Boulet S, Arveux P, Bonnetain F. A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection. Ann Oncol. 2009;20:1352–1361. doi: 10.1093/annonc/mdp016.
    1. Bonnetain F, Bouche O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, Bedenne L. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol. 2006;17:827–834. doi: 10.1093/annonc/mdl033.
    1. Post WJ, Buijs C, Stolk RP, de Vries EGE, Le Cessie S. The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach. Qual Life Res. 2010;19:137–148. doi: 10.1007/s11136-009-9564-1.
    1. Parker D. McCoy S, Moinpour C: Pattern mixture models for longitudinal quality of life studies in advanced stage disease. Stat Med. 2003;22:795–809. doi: 10.1002/sim.1397.
    1. Bonnetain F, Dahan L, Maillard L, Ychou M, Mitry E, Hammel P, Legoux JL, Rougier P, Bedenne L, Seitz JF. Time to definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer. 2010;46:2753–2762. doi: 10.1016/j.ejca.2010.07.023.
    1. Steinhauser KE, Voils CI, Clipp EC, Bosworth HB, Christakis NA, Tulsky JA. "Are you in peace?" One item to probe spiritual concerns at the end of life. Arch Intern Med. 2006;166:101–105. doi: 10.1001/archinte.166.1.101.
    1. Steinhauser KE, Alexander CA, Byock IR, George LK, Olsen MK, Tulsky JA. Do preparation and life completion discussions improve and quality of life in seriously ill patients? Pilot randomized control trial. J Palliat Med. 2008;11:1234–1240. doi: 10.1089/jpm.2008.0078.
    1. Bredart A, Dolbeault S. Evaluation de la qualité de vie en oncologie: I-définitions et objectifs. Revue Francophone de Psycho-Oncologie. 2005;4:7–12. doi: 10.1007/s10332-005-0047-5.
    1. Pantilat ZS. Communicating with seriously ill patients: better words to say. JAMA. 2009;301:1279–1281. doi: 10.1001/jama.2009.396.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel